Trademark Overview
On Monday, January 5, 2026, a trademark application was filed for ASTRALYN with the United States Patent and Trademark Office. The USPTO has given the ASTRALYN trademark a serial number of 99578972. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Monday, January 5, 2026. The ASTRALYN trademark is filed in the Pharmaceutical Products category with the following description:
Specialized tablets, capsules and powders for the delivery of pharmaceuticals sold without the pharmaceutical ingredient; Medicinal preparations for stimulating hair growth; Tobacco-free cigarettes for smoking cessation purposes; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for treating and preventing tendon and muscle injuries and disorders, sports related injuries, and for knee cartilage regeneration; Natural supplements for treating erectile dysfunction; Medicated skin care preparations, namely, creams, lotions, gels, toners, cleaners and peels; Gels, creams and solutions for dermatological use; Biocides, germicides, bactericides, virucides, fungicides, i...
